跳至主要内容
临床试验/NCT05593276
NCT05593276已完成不适用

The Preliminary Effects of an Internet-delivered, Layperson Facilitated Cognitive Behavioral Therapy for Depression Among Chronically Ill Older Adults: A Pilot Randomized Controlled Trial

University of Michigan2 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2023年1月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
70
试验地点
2
主要终点
Change in Patient Health Questionnaire-9 (PHQ-9)

研究概览

简要总结

This randomized pilot trial uses a waitlist control parallel design of a novel internet-based cognitive behavioral therapy program for older adults with elevated depressive symptoms. This study will enroll approximately 35 older adults per group throughout Michigan. The intervention will take approximately ten weeks to complete. Participants will have lower levels of depression after completing the intervention than before enrollment. Participants will be able to use the internet-based platform with minimal support.

详细描述

Depression affects up to 40% of homebound seniors, but most homebound seniors do not receive psychotherapy due to various access barriers. The study team focuses on developing community-based solutions to reduce these access barriers. In a previously approved project HUM00207612, the study team tested the feasibility of a novel internet-based cognitive behavioral therapy (iCBT) program called Empower@Home. The pilot project allowed for refining study procedures and the web platform used to deliver the program. In this new project, the study team will conduct a pilot randomized control trial to test the effectiveness of Empower@Home with older adults. Recruitment methods include 1) referrals from social service agencies, 2) advertisements on social media, local news outlets, and the program website, and 3) research participant registries.

The intervention involves attending up to 9 pre-recorded online therapy sessions and receiving weekly coaching calls from trained research assistants for up to 10 weeks. Participants will engage in therapy in their private homes. Three assessments are scheduled, including a comprehensive baseline, a post-test, and a 10-week follow-up. Each assessment takes about 20-40 minutes to complete over the phone.

Between Jan and Sept 2023, about 70 subjects (35 in each group) will be recruited. Participants will be randomized into the treatment group or waitlist control. The treatment group will receive the intervention immediately, whereas the waitlist control will wait for ten weeks before starting the intervention (i.e., after the 10-week "post-test"). Therefore, this is a cross-over design.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥60 years
  • have at least mild depressive symptoms, based on PHQ-9 >=8
  • are willing to participate

排除标准

  • Probable cognitive impairment based on the Blessed Orientation, Memory, and Concentration scale (score >9).
  • They do not speak English
  • have active suicidal ideation, defined as moderate to high risk based on the 6-item Columbia-Suicide Severity Rating Scale (C-SSRS)
  • Have a terminal illness or unstable physical health with a high risk of hospitalization within the next 3 months
  • Have severe vision impairment that can not be corrected and with no in-home help to assist them with using a mobile device
  • possible substance use disorders as assessed by the 4-item CAGE screener (>=2 on the CAGE AND have not been sober for at least one year)
  • Have a self reported psychotic disorder
  • Currently receiving psychotherapy

结局指标

主要结局

Change in Patient Health Questionnaire-9 (PHQ-9)

时间窗: Change from Baseline PHQ-9 at 10 weeks

Change in 9 item standardized measures of depressive symptom severity. PHQ-9 score ranges from 0 to 27, with a higher score indicating more severe symptoms.

Modified Treatment Evaluation Inventory

时间窗: 10 weeks

11-item Likert scale relating to acceptability of program to participant modified for older adults and the study context. The score ranges from 11 to 55, and a higher score means higher acceptability.

次要结局

  • Change in Generalized Anxiety Disorder Assessment-7 (GAD-7)(Change from Baseline at 10 weeks)
  • Change in Patient-Reported Outcomes Measurement Information Systems (PROMIS)-Global Health(Change from Baseline at 10 weeks)
  • Change in Patient-Reported Outcomes Measurement Information Systems (PROMIS)-Social Isolation(Change from Baseline at 10 weeks)
  • Change in EQ5D-5L(Change from Baseline at 10 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Xiaoling Xiang

Assistant Professor

University of Michigan

研究点 (2)

Loading locations...

相似试验